| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| UNII: | D40H7X1YZ0 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hodgkin Disease | 3 | D006689 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Esophageal Neoplasms | 1 | D004938 | ClinicalTrials |
| Liver Neoplasms | 1 | D008113 | ClinicalTrials |
| Uterine Cervical Neoplasms | 1 | D002583 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Nasopharyngeal Carcinoma | 1 | D000077274 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL5095352 |
| FDA SRS | D40H7X1YZ0 |
CONTENTS